Concepedia

Publication | Open Access

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

415

Citations

16

References

2022

Year

Abstract

ClinicalTrials.gov Identifier: NCT04063163.

References

YearCitations

Page 1